Inhibrx Biosciences, Inc. (INBX)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$99.50−$0.9000 (−0.90%) on the dayAs of the close; data may be delayed.
INBX price, last 12 months
Key stats
- Previous close
- $100.40
- Open
- $101.29
- Day range
- $98.09 – $101.29
- 52-week range
- $28.16 – $155.29
- Volume
- 123.6K
- Avg volume (20 days)
- 360.3K
- Market cap
- $1.5B
Performance
1W−9.0%
1M−20.6%
3M+5.0%
6M+51.2%
YTD+26.0%
1Y+235.0%
vs S&P 500, 1Y+218.2 pts
Technicals and fundamentals
About Inhibrx Biosciences, Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $1.5B